Detailed Information
Cited 14 time in 
Cited 0 time in 
Cited 0 time in
Metadata Downloads
Neoadjuvant giredestrant (GDC-9545) plus palbociclib (P) versus anastrozole (A) plus P in postmenopausal women with estrogen receptor-positive, HER2-negative, untreated early breast cancer (ER+/HER2-eBC): Final analysis of the randomized, open-label, international phase 2 coopERA BC study.
- Authors
- Fasching, PA[Fasching, Peter A.]; Bardia, A[Bardia, Aditya]; Quiroga, V[Quiroga, Vanesa]; Park, YH[Park, Yeon Hee]; Blancas, I[Blancas, Isabel]; Alonso, JL[Alonso, Jose Luis]; Vasilyev, A[Vasilyev, Alexander]; Adamchuk, H[Adamchuk, Hryhoriy]; Salgado, MRT[Salgado, Marcelo Ramos Tejo]; Yardley, DA[Yardley, Denise A.]; Spera, G[Spera, Gonzalo]; Xue, C[Xue, Cloris]; Ferreira, E[Ferreira, Erika]; Crnjevic, TB[Crnjevic, Tanja Badovinac]; Perez-Moreno, PD[Perez-Moreno, Pablo Diego]; Lopez-Valverde, V[Lopez-Valverde, Vanesa]; Steinseifer, J[Steinseifer, Jutta]; Fernando, TM[Fernando, Tharu M.]; Moore, HM[Moore, Heather M.]; Hurvitz, SA[Hurvitz, Sara A.]
- Issue Date
- 1-Jun-2022
- Publisher
- LIPPINCOTT WILLIAMS & WILKINS
- Citation
- JOURNAL OF CLINICAL ONCOLOGY, v.40, no.16
- Indexed
- SCIE
SCOPUS
- Journal Title
- JOURNAL OF CLINICAL ONCOLOGY
- Volume
- 40
- Number
- 16
- ISSN
- 0732-183X
- Files in This Item
- There are no files associated with this item.
- Appears in
Collections - Medicine > Department of Medicine > 1. Journal Articles
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.